HIV Treatment Compositions And Methods
US-2025255840-A1 · Aug 14, 2025 · US
This page is not indexed by search engines while we improve data quality.
Lee John H patents
Lee John H is listed as an inventor on 36 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Lee John H |
| Total patents | 36 |
| First publication | Nov 5, 2015 |
| Latest publication | Aug 14, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Correcting Audio Drift
US-2025239257-A1 · Jul 24, 2025 · US
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
US-12365874-B2 · Jul 22, 2025 · US
HIV treatment compositions and methods
US-12303477-B2 · May 20, 2025 · US
Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors
US-2025154465-A1 · May 15, 2025 · US
Novel mixer for emulsion products
US-2024424458-A1 · Dec 26, 2024 · US
Per-service storage of attributes
US-12093550-B2 · Sep 17, 2024 · US
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment
US-2024252540-A1 · Aug 1, 2024 · US
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment
US-11992504-B2 · May 28, 2024 · US
HIV Treatment Compositions And Methods
US-2023398186-A1 · Dec 14, 2023 · US
Recent patents
Latest publications not already listed above.
HIV treatment compositions and methods
US-11786577-B2 · Oct 17, 2023 · US
Method for treating Huntingtons's disease
US-11612641-B2 · Mar 28, 2023 · US
Per-service storage of attributes
US-2023029728-A1 · Feb 2, 2023 · US
HIV treatment compositions and methods
US-11311603-B2 · Apr 26, 2022 · US
Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors
US-2022025329-A1 · Jan 27, 2022 · US
Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors
US-11230699-B2 · Jan 25, 2022 · US
HIV Treatment Compositions And Methods
US-2022016214-A1 · Jan 20, 2022 · US
ACE2-Fc Trap
US-2021284716-A1 · Sep 16, 2021 · US
Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors
US-2021230547-A1 · Jul 29, 2021 · US
Screening of cell clones expressing polygenic transgenes through non-antibiotic dependent positive selection
US-2021169931-A1 · Jun 10, 2021 · US
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment
US-2021145879-A1 · May 20, 2021 · US
NK-92 Bone and Brain targeting
US-2021106619-A1 · Apr 15, 2021 · US
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
US-10960024-B2 · Mar 30, 2021 · US
Aldoxorubicin combination treatments and methods
US-2020352972-A1 · Nov 12, 2020 · US
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
US-2020101111-A1 · Apr 2, 2020 · US
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
US-2020093863-A1 · Mar 26, 2020 · US
Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapies
US-2020038441-A1 · Feb 6, 2020 · US
Hiv treatment compositions and methods
US-2019381141-A1 · Dec 19, 2019 · US
Modified doxorubicin compositions and methods
US-2019358201-A1 · Nov 28, 2019 · US
Polynucleotides for treating oncogenic viral polypeptide positive tumors
US-2018237477-A1 · Aug 23, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Nantkwest Inc | 10 |
| Nantcell Inc | 9 |
| Immunitybio Inc | 7 |
| Sanford Health | 4 |
| Emc Ip Holding Co Llc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K40/15 | 22 |
| C07K14/70535 | 20 |
| A61K40/31 | 20 |
| A61P35/00 | 19 |
| A61K35/17 | 18 |